FENC Fennec Pharmaceuticals Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$10,20
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$5,6552-Wochen-Tief
$13,2552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$357M
P/E (TTM)
-78.5
EPS (TTM)
$-0.13
Umsatz (TTM)
$59M
Ihre Abzeichen
52W-Spanne
$6–$13
Analystenbewertung
BUY
Kursziel
$18
P/E
-78.5
ROE
-18.6%
Nettogewinnmarge
-5.5%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
FENC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$10.20
Marktkapitalisierung (MRQ)
$357M
P/E (TTM)
-78.5
EPS (TTM)
$-0.13
Umsatz (TTM)
$59M
ROE (TTM)
-18.6%
52W-Spanne
$6–$13
FENC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$45M2017-12-31 → 2025-12-31
EPS$-0.342020-12-31 → 2025-12-31
Nettogewinnmarge-5.5%2023-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | FENC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -78.55-Jahres-Durchschnitt ≈-92.0 | ≈-92.0 | · | · | |
| P/S (TTM) | 6.05-Jahres-Durchschnitt ≈47.2 | ≈47.2 | 51.3 | Unterbewertet | |
| K/B (MRQ) | 8.45-Jahres-Durchschnitt ≈-36.7 | ≈-36.7 | 2.7 | Überbewertet | |
| Price / Cash Flow (Kurs / Cashflow) | -27.95-Jahres-Durchschnitt ≈-11.6 | ≈-11.6 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 9.8 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | FENC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -1.9%5-Jahres-Durchschnitt ≈-22.9% | ≈-22.9% | -483.3% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | -14.1%5-Jahres-Durchschnitt ≈-22.9% | ≈-22.9% | -482.3% | Spitzenklasse | |
| Pretax Margin (Vorgewinnmarge) | -21.6% | · | -673.1% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -5.5%5-Jahres-Durchschnitt ≈-32.7% | ≈-32.7% | -1172.5% | Spitzenklasse | |
| ROA (TTM) | -5.4%5-Jahres-Durchschnitt ≈-45.7% | ≈-45.7% | -43.7% | Spitzenklasse | |
| ROE (TTM) | -18.6%5-Jahres-Durchschnitt ≈-5068.0% | ≈-5068.0% | -57.1% | Schwach | |
| ROIC | -17.9% | · | -58.8% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | FENC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 5.85-Jahres-Durchschnitt ≈5.5 | ≈5.5 | 5.8 | Im Einklang | |
| Quick Ratio | 3.55-Jahres-Durchschnitt ≈3.6 | ≈3.6 | 3.3 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | FENC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -6.1%5-Jahres-Durchschnitt ≈467.4% | ≈467.4% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 207.5% | · | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 204.7% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | FENC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.85-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 0.0 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.3M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-41.9%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 11, 2026 | $0.05 | $0.01 | 400.0% |
| 31. März 2026 | Mai 14, 2026 | $0.01 | $-0.01 | — |
| 31. Dezember 2025 | $-0.10 | $0.04 | -380.1% | |
| 30. September 2025 | $-0.02 | $-0.02 | 8.3% | |
| 30. Juni 2025 | $-0.11 | $-0.04 | -199.7% | |
| 31. März 2025 | $-0.04 | $-0.09 | 55.8% | |
| 31. Dezember 2024 | $-0.06 | $0.17 | -135.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $48M | $21M | $2M | · | $200.0K | $0 | $0 | $0 | $0 | $0 | $0 | |
| Cost of Revenue | · | · | $1M | $86.0K | · | · | · | · | · | · | · | · | |
| Gross Profit | · | · | $20M | $1M | · | · | · | · | · | · | · | · | |
| R&D Expense | $250.0K | $307.0K | $56.0K | $4M | $5M | $5M | $6M | $5M | $2M | $472.0K | $256.0K | $357.0K | |
| SG&A Expense | $28M | $23M | $21M | $18M | $12M | $13M | $7M | $5M | $5M | $2M | $2M | $3M | |
| Operating Expenses | $51M | $45M | $34M | $24M | $17M | $18M | $13M | · | · | · | · | · | |
| Operating Income | $-6M | $3M | $-13M | $-23M | $-17M | $-18M | $-13M | $-10M | $-7M | $-3M | $-2M | $-3M | |
| Interest Income | $787.0K | $2M | $441.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-3M | $-3M | $-3M | $-1M | $-123.0K | $-224.0K | $-17.0K | $6.0K | $-8.0K | $-14.0K | $-9.0K | $701.0K | |
| Pretax Income | $-10M | $-71.0K | $-16M | · | · | · | · | · | $-7M | $-3M | $-658.0K | $-2M | |
| Income Tax | $106.0K | $365.0K | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-10M | $-436.0K | $-16M | $-24M | $-17M | $-18M | $-13M | $-10M | $-7M | $-3M | $-659.0K | $-2M | |
| EPS (Basic) | $-0.34 | $-0.02 | $-0.60 | $-0.90 | $-0.67 | $-0.76 | · | · | · | · | $-0.06 | $-0.22 | |
| EPS (Diluted) | $-0.34 | $-0.02 | $-0.60 | $-0.90 | $-0.67 | $-0.76 | · | · | · | · | $-0.06 | $-0.22 | |
| Shares (Basic) | 28,577,000 | 27,294,000 | 26,574,000 | 26,275,000 | 26,006,000 | 23,704 | 19,896,000 | 18,942,000 | 15,014,000 | 12,765,000 | 10,827,000 | 9,871,000 | |
| Shares (Diluted) | 28,577,000 | 27,294,000 | 26,574,000 | 26,275,000 | 26,006,000 | 23,704 | 19,896,000 | 18,942,000 | 15,014,000 | 12,765,000 | 10,827,000 | 9,871,000 | |
| EBITDA | $-6M | $3M | $-13M | $-23M | $-17M | $-18M | $-13M | $-10M | $-7M | $-3M | $-2M | $-3M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $27M | $13M | $24M | $21M | $30M | $14M | $23M | $28M | $4M | $942.0K | $2M | |
| Prepaid Expense | $4M | $3M | $3M | $770.0K | $1M | $797.0K | $226.0K | $168.0K | $128.0K | $43.0K | $76.0K | $48.0K | |
| Other Current Assets | $2M | $466.0K | $44.0K | $63.0K | $253.0K | $276.0K | $8.0K | $1.0K | $13.0K | $3.0K | $1.0K | $17.0K | |
| Current Assets | $67M | $44M | $27M | $27M | $22M | $31M | $14M | $23M | $28M | · | · | · | |
| Other Non-current Assets | $717.0K | $822.0K | $816.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $71M | $45M | $27M | $27M | $22M | $31M | $14M | $23M | $28M | $4M | $1M | $2M | |
| Accounts Payable | $5M | $3M | $4M | $2M | $777.0K | $2M | $2M | $1M | $855.0K | $244.0K | $297.0K | $308.0K | |
| Accrued Liabilities | $6M | $3M | $4M | $2M | $877.0K | $776.0K | $659.0K | $605.0K | $622.0K | $125.0K | $92.0K | $132.0K | |
| Current Liabilities | $11M | $7M | $8M | $5M | $2M | $2M | $2M | $2M | $2M | $402.0K | $471.0K | $2M | |
| Capital Leases | · | · | $2.0K | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $35M | $51M | $38M | $30M | $7M | $2M | $2M | $2M | $2M | $402.0K | $471.0K | $2M | |
| Long-term Debt | · | $19M | $31M | $25M | · | · | · | · | · | · | · | · | |
| Common Stock | $190M | $146M | $144M | $143M | $141M | $141M | $106M | $106M | $103M | $75M | $69M | $69M | |
| Retained Earnings | $-229M | $-220M | $-219M | $-203M | $-179M | $-162M | $-144M | $-131M | $-121M | $-114M | $-112M | $-111M | |
| AOCI | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stockholders' Equity | $35M | $-6M | $-12M | $-3M | $16M | $29M | $12M | $21M | $27M | $4M | $548.0K | $613.0K | |
| Liabilities + Equity | $71M | $45M | $27M | $27M | $22M | $31M | $14M | $23M | $28M | $4M | $1M | $2M | |
| Shares Outstanding | 34,163,000 | 27,527,000 | 27,027,000 | 26,361,000 | 26,014,000 | 26,003,000 | 19,896,000 | 19,896,000 | 18,411,000 | 13,643,000 | 10,940,000 | 10,593,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $5M | $5M | $4M | $4M | $3M | $3M | $2M | $2M | $615.0K | $97.0K | $627.0K | |
| Operating Cash Flow | $-12M | $27M | $-17M | $-18M | $-14M | $-16M | $-9M | $-8M | $-4M | $-2M | $-2M | $-2M | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | |
| Debt Issued | · | · | $5M | $25M | $5M | · | · | · | · | · | · | · | |
| Net Debt Issued | $-19M | $-13M | $5M | $25M | $5M | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | $32M | $0 | $0 | $27M | $5M | $0 | $2M | |
| Net Stock Activity | · | · | · | · | · | $32M | · | $0 | $27M | $5M | $0 | $2M | |
| Financing Cash Flow | $23M | $-14M | $7M | $21M | $5M | $32M | $-71.0K | $2M | $28M | $5M | · | $2M | |
| Net Change in Cash | $10M | $13M | $-11M | $3M | $-9M | $17M | $-9M | $-5M | $24M | $3M | $-1M | $644.0K | |
| Taxes Paid | $748.0K | · | · | · | · | · | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 94.1% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -14.1% | 5.4% | -60.1% | · | · | · | · | · | · | · | · | · | |
| Net Margin | -21.8% | -0.92% | -75.5% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -21.6% | -0.15% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -14.1% | 5.4% | -60.1% | · | · | · | · | · | · | · | · | · | |
| ROA | -16.9% | -1.2% | -68.5% | -96.1% | -64.5% | -79.5% | -68.9% | -38.5% | -43.5% | -111.8% | -38.9% | -105.5% | |
| ROE | -69.6% | 7.9% | 144.9% | -20355.4% | -99.7% | -60.1% | -95.1% | -44.8% | -38.7% | -71.6% | -84.1% | 107.6% | |
| ROIC | -17.9% | -268.6% | · | · | · | · | · | · | -26.0% | -80.4% | · | -469.3% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.4 | 6.4 | 3.6 | 5.8 | 13.5 | 13.4 | 6.1 | · | · | · | · | · | |
| Quick Ratio | 3.5 | 3.8 | 1.8 | 5.2 | 12.8 | 12.9 | 6.0 | 13.9 | 17.2 | 9.8 | 2.0 | 1.3 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.3 | 0.9 | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.04 | $-0.21 | $-0.43 | $-0.10 | $0.61 | $1.12 | $0.60 | $1.07 | $1.45 | $0.26 | $0.05 | $0.06 | |
| Revenue / Share | $1.56 | $1.74 | $0.80 | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Cash Flow / Share | $-0.44 | $0.99 | $-0.65 | $-0.69 | $-546.87 | $-0.66 | $-0.46 | $-0.41 | $-0.24 | $-0.17 | $-0.17 | $-0.17 | |
| Cash / Share | $1.08 | $0.97 | $0.49 | $0.90 | $0.81 | $1.17 | $0.69 | $1.15 | $1.53 | $0.29 | $0.09 | $0.22 | |
| EPS (TTM) | $-0.34 | $-0.02 | $-0.60 | $-0.90 | $-0.67 | $-0.76 | $-0.33 | $-0.52 | $-0.36 | $-0.15 | $-0.06 | $-0.22 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -6.1% | 123.7% | 1284.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 207.5% | · | 400.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 204.7% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45M | $48M | $21M | $2M | $0 | $200.0K | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-10M | $-436.0K | $-16M | $-24M | $-17M | $-18M | $-13M | $-10M | $-7M | $-3M | $-659.0K | $-2M | |
| Market Cap | $263M | $174M | $303M | $253M | $114M | $194M | $129M | $127M | $184M | · | · | · | |
| P/E | -22.6 | -316.0 | -18.7 | -10.7 | -6.6 | -9.8 | -19.7 | -12.3 | -27.8 | · | · | · | |
| P/S | 5.9 | 3.7 | 14.3 | 164.9 | · | 968.6 | · | · | · | · | · | · | |
| P/B | 7.4 | -29.6 | -26.1 | -98.5 | 7.3 | 6.7 | 10.9 | 6.0 | 6.9 | · | · | · | |
| P / Tangible Book | 7.4 | · | · | · | 7.3 | 6.7 | · | · | · | · | · | · | |
| P / Cash Flow | -21.1 | 6.4 | -17.7 | -14.0 | -8.0 | -12.4 | -14.3 | -16.2 | -50.7 | · | · | · | |
| Earnings Yield | -4.4% | -0.32% | -5.3% | -9.4% | -15.2% | -10.2% | -5.1% | -8.2% | -3.6% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18M | $15M | $14M | $12M | $10M | $9M | $8M | $7M | $7M | $25M | $10M | $7M | $3M | $2M | · | · | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | $331.0K | $148.0K | $95.0K | · | · | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $6M | $3M | $2M | · | · | |
| R&D Expense | $118.0K | $49.0K | $20.0K | $29.0K | $107.0K | $94.0K | $50.0K | $97.0K | $157.0K | $3.0K | $32.0K | $12.0K | $8.0K | $4.0K | $117.0K | $846.0K | |
| SG&A Expense | $5M | $3M | $8M | $7M | $7M | $6M | $4M | $6M | $7M | $6M | $7M | $4M | $5M | $4M | $5M | $7M | |
| Operating Expenses | $16M | $15M | $16M | $13M | $12M | $10M | $9M | $12M | $12M | $12M | $12M | $8M | $8M | $7M | $18M | $8M | |
| Operating Income | $2M | $-119.0K | $-3M | $-189.0K | $-3M | $-808.0K | $-934.0K | $-5M | $-5M | $14M | $-2M | $-1M | $-5M | $-5M | $-6M | $-8M | |
| Interest Income | $287.0K | $339.0K | $228.0K | $152.0K | $171.0K | $236.0K | $399.0K | $516.0K | $570.0K | $197.0K | $115.0K | $102.0K | · | · | · | · | |
| Other Non-op | $278.0K | $320.0K | $-2M | $-449.0K | $-420.0K | $-357.0K | $-686.0K | $-533.0K | $-514.0K | $-906.0K | $-864.0K | $-850.0K | $-778.0K | $-782.0K | $-722.0K | $-190.0K | |
| Pretax Income | $2M | · | · | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $42.0K | · | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $2M | $201.0K | $-5M | $-638.0K | $-3M | $-1M | $-2M | $-6M | $-6M | $13M | $-3M | $-2M | $-5M | $-6M | $-7M | $-8M | |
| EPS (Basic) | $0.06 | $0.01 | $-0.17 | $-0.02 | $-0.11 | $-0.04 | $-0.08 | $-0.21 | $-0.20 | $0.47 | $-0.09 | $-0.07 | $-0.21 | $-0.23 | $-0.26 | $-0.31 | |
| EPS (Diluted) | $0.05 | $0.01 | $-0.17 | $-0.02 | $-0.11 | $-0.04 | $-0.02 | $-0.21 | $-0.20 | $0.41 | $-0.09 | $-0.07 | $-0.21 | $-0.23 | $-0.26 | $-0.31 | |
| Shares (Basic) | 34,545,000 | 34,336,000 | · | 27,889,000 | 27,664,000 | 27,578,000 | · | 27,371,000 | 27,297,000 | 27,045,000 | · | 26,596,000 | 26,458,000 | 26,559,000 | · | 26,108,000 | |
| Shares (Diluted) | 36,430,000 | 35,548,000 | · | 27,889,000 | 27,664,000 | 27,578,000 | · | 27,371,000 | 27,297,000 | 31,091,000 | · | 26,596,000 | 26,458,000 | 26,559,000 | · | 26,108,000 | |
| EBITDA | $2M | $-119.0K | · | $-189.0K | $-3M | $-808.0K | · | $-5M | · | $14M | · | $-1M | $-5M | $-5M | · | $-8M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $40M | $37M | $22M | $19M | $23M | $27M | $40M | $43M | $51M | $13M | $12M | $15M | $18M | $24M | $30M | |
| Prepaid Expense | $4M | $3M | $4M | $1M | $1M | $2M | $3M | $3M | $4M | $4M | $3M | $247.0K | $457.0K | $639.0K | $770.0K | $278.0K | |
| Other Current Assets | $2M | $3M | $2M | $898.0K | $965.0K | $1M | $466.0K | $546.0K | $283.0K | $161.0K | $44.0K | $20.0K | $32.0K | $32.0K | $63.0K | $123.0K | |
| Current Assets | $72M | $67M | $67M | $46M | $41M | $43M | $44M | $58M | $62M | $68M | $27M | $19M | $19M | $22M | $27M | $30M | |
| Other Non-current Assets | $666.0K | $691.0K | $717.0K | $743.0K | $768.0K | $794.0K | $822.0K | $956.0K | $989.0K | $1M | $816.0K | · | · | · | · | · | |
| Total Assets | $76M | $72M | $71M | $49M | $45M | $46M | $45M | $59M | $63M | $69M | $27M | $19M | $19M | $22M | $27M | $30M | |
| Accounts Payable | $6M | $6M | $5M | $6M | $6M | $5M | $3M | $4M | $4M | $5M | $4M | $3M | $3M | $3M | $2M | $3M | |
| Accrued Liabilities | $4M | $3M | $6M | $4M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $951.0K | $773.0K | $1M | $2M | $394.0K | |
| Current Liabilities | $12M | $10M | $11M | $10M | $8M | $8M | $7M | $7M | $8M | $10M | $8M | $4M | $4M | $4M | $5M | $3M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | $7.0K | · | · | · | · | |
| Total Liabilities | $33M | $34M | $35M | $54M | $52M | $52M | $51M | $64M | $65M | $66M | $38M | $30M | $29M | $29M | $30M | $28M | |
| Long-term Debt | · | · | · | $19M | $19M | $19M | · | $32M | $32M | $31M | · | $26M | $25M | $25M | · | $25M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | |
| Common Stock | $193M | $191M | $190M | $148M | $146M | $146M | $146M | $145M | $145M | $145M | $144M | $144M | $143M | $143M | $143M | $141M | |
| Retained Earnings | $-227M | $-229M | $-229M | $-225M | $-224M | $-221M | $-220M | $-218M | $-212M | $-206M | $-219M | $-217M | $-215M | $-209M | $-203M | $-196M | |
| AOCI | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stockholders' Equity | $42M | $38M | $35M | $-4M | $-7M | $-6M | $-6M | $-5M | $-1M | $3M | $-12M | $-11M | $-10M | $-7M | $-3M | $3M | |
| Liabilities + Equity | $76M | $72M | $71M | $49M | $45M | $46M | $45M | $59M | $63M | $69M | $27M | $19M | $19M | $22M | $27M | $30M | |
| Shares Outstanding | 35,034,000 | 34,541,000 | 34,163,000 | 28,062,000 | 27,733,000 | 27,594,000 | 27,527,000 | 27,422,000 | 27,329,000 | 27,105,000 | 27,027,000 | 26,635,000 | 26,509,000 | 26,411,000 | 26,361,000 | 26,238,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $990.0K | $3M | $2M | $1M | $798.0K | $1M | $2M | $925.0K | $1M | $857.0K | $865.0K | $3M | $1M | $827.0K | $2M | |
| Operating Cash Flow | $50.0K | $2M | $-6M | $1M | $-4M | $-4M | $-1M | $-2M | $-8M | $39M | $-5M | $-3M | $-4M | $-6M | $-7M | $-5M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-65.0K | · | |
| Financing Cash Flow | $1M | $1M | $21M | $2M | $-284.0K | $359.0K | $-12M | $-528.0K | $257.0K | $-1M | $6M | $201.0K | $514.0K | $193.0K | $824.0K | $20M | |
| Net Change in Cash | $1M | $3M | $15M | $3M | $-4M | $-4M | $-14M | $-3M | $-8M | $38M | $870.0K | $-3M | $-3M | $-5M | $-6M | $15M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 94.9% | · | · | · | · | |
| Operating Margin | 9.7% | -0.79% | · | -1.5% | -28.3% | -9.2% | · | -74.6% | · | 54.2% | · | -15.6% | · | · | · | · | |
| Net Margin | 11.0% | 1.3% | · | -5.1% | -32.7% | -13.3% | · | -82.2% | · | 50.6% | · | -28.7% | · | · | · | · | |
| Pretax Margin | 11.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 9.7% | -0.79% | · | -1.5% | -28.3% | -9.2% | · | -74.6% | · | 54.2% | · | -15.6% | · | · | · | · | |
| ROA | 3.3% | 0.34% | · | -1.2% | -5.8% | -2.0% | · | -14.7% | · | 28.2% | · | -7.5% | -31.1% | -29.5% | · | -28.7% | |
| ROE | 11.3% | 1.3% | · | 13.2% | 71.5% | 81.3% | · | 73.0% | · | -593.6% | · | 48.3% | 918.0% | -233.4% | · | -74.2% | |
| ROIC | 4.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.8 | 7.0 | · | 4.7 | 4.8 | 5.1 | · | 7.8 | · | 6.9 | · | 4.8 | 5.1 | 5.4 | · | 10.3 | |
| Quick Ratio | 3.3 | 4.2 | · | 2.2 | 2.2 | 2.7 | · | 5.4 | · | 5.2 | · | 3.2 | 4.0 | 4.6 | · | 10.2 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 8.9 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 8.9 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | · | 0.6 | · | 0.3 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.21 | $1.09 | · | $-0.16 | $-0.27 | $-0.21 | · | $-0.19 | · | $0.11 | · | $-0.40 | $-0.37 | $-0.28 | · | $0.11 | |
| Revenue / Share | $0.49 | $0.42 | · | $0.45 | $0.35 | $0.32 | · | $0.25 | · | $0.82 | · | $0.24 | · | · | · | · | |
| Cash Flow / Share | · | $0.07 | · | · | · | $-0.16 | · | · | · | $1.26 | · | · | · | $-0.21 | · | · | |
| Cash / Share | $1.18 | $1.16 | · | $0.78 | $0.67 | $0.82 | · | $1.47 | · | $1.89 | · | $0.47 | $0.56 | $0.70 | · | $1.13 | |
| EPS (TTM) | $-0.13 | $-0.29 | · | $-0.19 | $-0.38 | $-0.47 | · | $-0.09 | $-0.07 | $0.04 | · | $-0.77 | $-1.01 | $-0.99 | · | $-0.82 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $59M | $51M | · | $39M | $33M | $31M | · | $49M | $42M | $45M | · | · | · | · | · | $170.0K | |
| Net Income TTM | $-3M | $-8M | · | $-7M | $-12M | $-14M | · | $-1M | $-27.0K | $3M | · | $-20M | $-26M | $-26M | · | $-21M | |
| Market Cap | $377M | $212M | · | $263M | $230M | $168M | · | $137M | · | $301M | · | $200M | $234M | $220M | · | $213M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $208M | |
| P/E | -82.7 | -21.2 | · | -49.3 | -21.8 | -13.0 | · | -55.6 | -87.3 | 278.0 | · | -9.8 | -8.7 | -8.4 | · | -9.9 | |
| P/S | 6.4 | 4.2 | · | 6.8 | 6.9 | 5.4 | · | 2.8 | · | 6.7 | · | · | · | · | · | 1250.2 | |
| P/B | 8.9 | 5.6 | · | -58.5 | -30.8 | -28.6 | · | -26.5 | · | 100.0 | · | -19.0 | -24.1 | -29.9 | · | 75.8 | |
| P / Tangible Book | 8.9 | 5.6 | · | · | · | · | · | · | · | 100.0 | · | · | · | · | · | 75.8 | |
| P / Cash Flow | · | 89.3 | · | · | · | -38.9 | · | · | · | 7.7 | · | · | · | -39.4 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 1222.2 | |
| Earnings Yield | -1.2% | -4.7% | · | -2.0% | -4.6% | -7.7% | · | -1.8% | -1.1% | 0.36% | · | -10.2% | -11.4% | -11.9% | · | -10.1% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Umsatz | $45M | $48M | $21M | · | $2M |
| Bruttogewinnmarge % | · | · | 94.1% | · | · |
| Betriebsgewinnmarge % | -14.1% | 5.4% | -60.1% | · | · |
| Nettoergebnis | $-10M | $-436.0K | $-16M | · | $-24M |
| Verwässerte EPS | $-0.34 | $-0.02 | $-0.60 | · | $-0.90 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 6.4 | 6.4 | 3.6 | · | 5.8 |
| Quick Ratio | 3.5 | 3.8 | 1.8 | · | 5.2 |
Keine Daten für diese Aufstellung
Noch nicht genügend Fundamentaldaten vorhanden, um diese Aufstellung zu erstellen.
Institutionelle Eigentümer (13F) 110 Einreicher · $182.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
110
Gehaltener Wert
$182.8M
Neue Positionen
25
Geschlossene Positionen
8
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 25 (+8 vs. Vorquartal) | 8 (-11 vs. Vorquartal) | 44 (+6 vs. Vorquartal) | 18 (+1 vs. Vorquartal) | +136K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $34.271.011 | 3.188.001 | 18,74% | Aktien |
| AIGH Capital Management LLC | $26.724.908 | 2.486.038 | 14,62% | Aktien |
| Solas Capital Management, LLC | $20.310.685 | 1.889.366 | 11,11% | Aktien |
| BlackRock, Inc. | $18.565.992 | 1.727.069 | 10,15% | Aktien |
| AWM Investment Company, Inc. | $12.473.182 | 1.160.296 | 6,82% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.022.540 | 839.306 | 4,93% | Aktien |
| VANGUARD GROUP INC | $8.220.912 | 1.067.651 | 4,50% | Aktien |
| Prospect Capital Advisors, LLC | $5.351.350 | 497.800 | 2,93% | Aktien |
| STATE STREET CORP | $4.579.543 | 426.004 | 2,50% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.327.584 | 402.566 | 2,37% | Aktien |
| JANE STREET GROUP, LLC | $2.514.178 | 233.877 | 1,38% | Aktien |
| Potomac Capital Management, Inc. | $2.412.300 | 224.400 | 1,32% | Aktien |
| MORGAN STANLEY | $2.385.640 | 221.920 | 1,30% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.149.979 | 199.998 | 1,18% | Aktien |
| NORTHERN TRUST CORP | $1.805.162 | 167.922 | 0,99% | Aktien |
| MARSHALL WACE, LLP | $1.491.651 | 138.758 | 0,82% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.442.650 | 134.200 | 0,79% | Aktien |
| Nuveen, LLC | $1.413.432 | 131.482 | 0,77% | Aktien |
| Trexquant Investment LP | $1.280.562 | 119.122 | 0,70% | Aktien |
| CenterBook Partners LP | $1.274.757 | 118.582 | 0,70% | Aktien |
| Lion Point Capital, LP | $1.208.666 | 112.434 | 0,66% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1.161.054 | 108.005 | 0,63% | Aktien |
| Cornerstone Capital, Inc. | $1.128.750 | 105.000 | 0,62% | Aktien |
| XTX Topco Ltd | $1.009.060 | 93.866 | 0,55% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $998.557 | 92.889 | 0,55% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $908.892 | 84.548 | 0,50% | Aktien |
| Quadrature Capital Ltd | $814.055 | 75.726 | 0,45% | Aktien |
| CITADEL ADVISORS LLC | $763.594 | 71.032 | 0,42% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $757.918 | 70.504 | 0,41% | Aktien |
| 1492 Capital Management LLC | $700.352 | 65.149 | 0,38% | Aktien |
| Bank of New York Mellon Corp | $656.098 | 61.032 | 0,36% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $648.569 | 60.332 | 0,35% | Aktien |
| Qube Research & Technologies Ltd | $626.639 | 58.292 | 0,34% | Aktien |
| Point72 Asset Management, L.P. | $606.375 | 56.407 | 0,33% | Aktien |
| Hartford Financial Management Inc. | $544.445 | 50.646 | 0,30% | Aktien |
| Round Rock Advisors LLC | $523.342 | 48.683 | 0,29% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $488.050 | 45.400 | 0,27% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $415.004 | 38.605 | 0,23% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $394.815 | 36.727 | 0,22% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $378.400 | 35.200 | 0,21% | Kaufoption |
| RHUMBLINE ADVISERS | $375.911 | 34.969 | 0,21% | Aktien |
| GOLDMAN SACHS GROUP INC | $359.609 | 33.452 | 0,20% | Aktien |
| Squarepoint Ops LLC | $334.669 | 31.132 | 0,18% | Aktien |
| Eleva Capital SAS | $327.389 | 53.234 | 0,18% | Aktien |
| PRELUDE CAPITAL MANAGEMENT, LLC | $318.189 | 29.599 | 0,17% | Aktien |
| DEUTSCHE BANK AG\ | $310.654 | 28.898 | 0,17% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $287.093 | 26.052 | 0,16% | Aktien |
| WELLS FARGO & COMPANY/MN | $285.563 | 26.564 | 0,16% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $282.908 | 26.317 | 0,15% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $272.094 | 25.311 | 0,15% | Aktien |
Aktivisten & 5%+-Eigentümer 7 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Essetifin S.p.A. (2), Paolo Cavazza (2), Enrico Cavazza (2), Francesca Cavazza (2), Silvia Cavazza (2), Martina Cavazza Preta (2) ×2 Einreichungen | 4. Mai 2020 | · | Erste Einreichung | · | SEC |
| Manchester Management PR, LLC, Manchester Management Company, LLC, Manchester Explorer, L.P., James E. Besser, Morgan C. Frank ×5 Einreichungen | 10. September 2018 | · | Erste Einreichung | · | SEC |
| Varana Capital, LLC, Varana Capital Partners, LP, Varana Capital Focused, LP, Philip Broenniman, Ezra Gardner | 18. Mai 2017 | · | Erste Einreichung | Passive Anlage | SEC |
| Manchester Management Company, LLC, Manchester Explorer, L.P., JEB Partners, L.P., James E. Besser, Morgan C. Frank | 26. November 2013 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter | 9. September 2010 | · | Erste Einreichung | · | SEC |
| Southpoint Master Fund, LP, Southpoint Fund LP, Southpoint Qualified Fund LP, Southpoint Offshore Fund, Ltd., Southpoint Capital Advisors LP, Southpoint GP, LP, Southpoint Capital Advisors LLC, Southpoint GP, LLC, John S. Clark II ×6 Einreichungen | 30. August 2010 | · | Erste Einreichung | · | SEC |
| Robert W. Butts (2) | 14. Juni 2010 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 25 Insider · 11 Führungskräfte · 14 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jeffrey S. Hackman | Chief Executive Officer | 30. September 2026 A | 67.461 | 0 | 0 | $0 |
| William P Peters | Chairman and CEO | 27. Februar 2008 A | · | 0 | 0 | $0 |
| Robert Andrade | CHIEF FINANCIAL OFFICER | 30. September 2026 A | 243.009 | 0 | 1 | $-883.500 |
| James A Klein JR | CFO | 27. Februar 2008 A | · | 0 | 0 | $0 |
| Adrian Haigh | CHIEF OPERATING OFFICER | 16. Mai 2024 A | 44.444 | 0 | 0 | $0 |
| Christiana Marie Cioffi | Chief Strategy Officer | 30. September 2026 A | 24.800 | 0 | 0 | $0 |
| Pierre Sargis Sayad | Chief Medical Officer | 30. September 2026 A | 9.687 | 0 | 1 | $-146.160 |
| Terry L Evans | Chief Commercial Officer | 30. September 2026 A | 21.687 | 0 | 0 | $0 |
| Shubh Goel | Chief Commercial Officer | 20. Dezember 2021 A | · | 0 | 0 | $0 |
| Thomas Spector | NA | 18. August 2010 A | · | 0 | 0 | $0 |
| Scott D Murray | SVP, Gen Counsel & Corp Secty | 27. Februar 2008 A | · | 0 | 0 | $0 |
| Marco Maria Brughera | Direktor | 15. September 2026 M | 0 | 0 | 1 | $-159.958 |
| Jodi A Cook | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Khalid Islam | Direktor | 10. Juni 2026 A | 213.825 | 0 | 0 | $0 |
| Chris A Rallis | Direktor | 10. Juni 2026 A | 63.077 | 0 | 2 | $-75.157 |
| Claudio F Bussandri | Direktor | 18. August 2010 A | · | 0 | 0 | $0 |
| William G Breen | Direktor | 18. August 2010 A | · | 0 | 0 | $0 |
| Arthur T Porter | Direktor | 18. August 2010 A | · | 0 | 0 | $0 |
| Robert W Butts | Direktor | 8. Juni 2010 P | 41.504.000 | 0 | 0 | $0 |
| Michael G Martin | Direktor | 3. Dezember 2007 A | · | 0 | 0 | $0 |
| Donald W Kufe | Direktor | 3. Dezember 2007 A | · | 0 | 0 | $0 |
| Peter Morand | Direktor | 3. Dezember 2007 A | · | 0 | 0 | $0 |
| Fred H Mermelstein | Direktor | 3. Dezember 2007 A | · | 0 | 0 | $0 |
| Rosty Raykov | · | 1. September 2026 S | 124.411 | 0 | 12 | $-1.046.553 |
| Robin J Norris | · | 16. November 2009 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 8 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,08% | 98.294 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 272.693 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 30.929 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 739.746 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 166.974 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 13.889 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 815.192 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.095 SH | 19. August 2026 | Täglich |
FENC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 12 Analysten
KAUF
Median-Ziel
$18.00
+76,5%
3 25,0%
Starker Kauf
8 66,7%
Kauf
1 8,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-10-01Mittelwert-Ziel $17.67 +73,2%
← Unter allen Zielen
Aktueller Preis $10.20
Tief$16.00
Mittelwert$17.67
Hoch$20.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | · |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | · |
| ZNTL | $93M | -0.7 | · | · | -49.5% | · |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | · |
| INDP | $6M | -0.1 | · | · | -2820.8% | · |
| SRZN | · | · | · | · | · | · |
| CYPH | $97M | 16.6 | · | · | 6.1% | · |
| ARTV | · | -1.3 | -99.2% | · | · | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026